Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG
Diana Carvalho(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Jessica K.R. Boult(Institute of Cancer Research), Safa Al‐Sarraj(King's College Hospital), Paula Proszek(BMW (Germany)), Yura Grabovska(Newcastle University), Franco Locatelli(Bambino Gesù Children's Hospital), Michelle Monje(Howard Hughes Medical Institute), Jane Pears(Our Lady's Hospital), Jane Cryan(Broad Institute), Bassam Dabbous(St George's Hospital), Fernando Carceller, Bassel Zebian(King's College London), Michael Hubank(Royal Marsden Hospital), Matthew Clarke(Institute of Cancer Research), Valeria Molinari(Institute of Cancer Research), Evelina Miele(Bambino Gesù Children's Hospital), Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Elisa Izquierdo(Institute of Cancer Research), Ranj Bhangoo(King's College Hospital), Sucheta Vaidya(Royal Marsden Hospital), Helen N. Pemberton(Institute of Cancer Research), Sara Temelso(Institute of Cancer Research), Tim Hassall(St. Jude Children's Research Hospital), Elisabet F Potente(Institute of Cancer Research), Robert K. Johnston(Royal Belfast Hospital for Sick Children), Giulia Pericoli(Bambino Gesù Children's Hospital), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Alan Mackay(Institute of Cancer Research), Rebecca F. Rogers(Institute of Cancer Research), Nagore G. Olaciregui(Sant Joan de Déu Research Foundation), Samantha Hettige(St George's Hospital), Ketty Kessler(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Darach Crimmins(Temple Street Children's University Hospital), Henry Mandeville(Royal Marsden Hospital), Janat Fazal Salom(Institute of Cancer Research), Mariama Fofana(Institute of Cancer Research), Andrea Carai(Bambino Gesù Children's Hospital), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Michael A. Farrell(Temple Street Children's University Hospital), Andrew J. Martin(St George's Hospital), Simon P. Robinson(Institute of Cancer Research), Lynn Bjerke(Institute of Cancer Research), Leslie Bridges(St George's Hospital), Simon Stapleton(St George's Hospital), John Caird(Temple Street Children's University Hospital), Angela Mastronuzzi(Bambino Gesù Children's Hospital), Christopher Chandler(University Hospitals Sussex NHS Foundation Trust), Kathryn R. Taylor(Stanford University)
Cited by 7
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k